← Leaderboards
Xiaoming Hu
Veterans Health Administration
$4,832,813
Attributed
$5,613,264
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,613,264 · 5
VA$0 · 3
By mechanism
R01$3,835,825 · 3
RF1$1,357,361 · 1
R21$420,078 · 1
I01$0 · 3
Top collaborators
- Jun Chen3 shared
- Rehana Khan Leak2 shared
Most similar at Veterans Health Administration
Same institution · by research overlap
- Dandan Sun$18,130,400
- Hallie Christine Prescott$2,444,964
- Kejie Yin$6,302,196
- C Edward Dixon$15,159,208
- Jeremy Broder Sussman$0
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoBrainInflammatoryIn VitroInflammationWhite MatterMicrogliaStrokeMacrophageCytokineKnockout MicePhenotypeWhite Matter InjuryFutureAttenuatedProductionExhibitsRecoveryPlayReceptorCellsOligodendrogliaNeurological RecoveryIschemic Stroke
Grant awards (23)
Adiponectin on cerebrovascular regulation in vascular cognitive impairment and dementia (VCID)$357,750
R01 · FY2025 · NS · contact PI
Repopulation of the Microglia/Macrophage Niche in Experimental Lewy Body Disease$188,252
R21 · FY2025 · NS
Novel immune therapy to promote functional recovery after traumatic brain injury$0
I01 · FY2025 · VA · contact PI
Targeting monocyte derived macrophage for stroke treatment$0
I01 · FY2025 · VA · contact PI
Adiponectin on cerebrovascular regulation in vascular cognitive impairment and dementia (VCID)$385,575
R01 · FY2024 · NS · contact PI
Repopulation of the Microglia/Macrophage Niche in Experimental Lewy Body Disease$231,826
R21 · FY2024 · NS
Novel immune therapy to promote functional recovery after traumatic brain injury$0
I01 · FY2024 · VA · contact PI
White Matter Injury and Repair in Vascular Cognitive Impairment and Dementia$1,357,361
RF1 · FY2023 · NS · contact PI
Adiponectin on cerebrovascular regulation in vascular cognitive impairment and dementia (VCID)$397,500
R01 · FY2023 · NS · contact PI
Interleukin-33 as an immune therapy for stroke$0
I01 · FY2023 · VA · contact PI
Novel immune therapy to promote functional recovery after traumatic brain injury$0
I01 · FY2023 · VA · contact PI
Interleukin-33 as an immune therapy for stroke$0
I01 · FY2022 · VA · contact PI
Interleukin-33 as an immune therapy for stroke$0
I01 · FY2021 · VA · contact PI
Immunomodulation of white matter integrity after stroke$336,875
R01 · FY2020 · NS · contact PI
Interleukin-33 as an immune therapy for stroke$0
I01 · FY2020 · VA · contact PI
Interleukin-33 as an immune therapy for stroke$0
I01 · FY2019 · VA · contact PI
Regulatory T cell as a restorative therapy for ischemic stroke$336,875
R01 · FY2018 · NS · contact PI
Immunomodulation of white matter integrity after stroke$336,875
R01 · FY2018 · NS · contact PI
Immunomodulation of white matter integrity after stroke$336,875
R01 · FY2017 · NS · contact PI
Regulatory T cell as a restorative therapy for ischemic stroke$336,875
R01 · FY2017 · NS · contact PI
Regulatory T cell as a restorative therapy for ischemic stroke$336,875
R01 · FY2016 · NS · contact PI
Immunomodulation of white matter integrity after stroke$336,875
R01 · FY2016 · NS · contact PI
Immunomodulation of white matter integrity after stroke$336,875
R01 · FY2015 · NS · contact PI